Yat Sun Or, Chief Scientific Officer at ENANTA PHARMACEUTICALS INC (ENTA), sold 5,000 shares at $37.23 ($185K) on 2014-05-01, disclosed to the SEC on 2014-05-02.
Scheduled sale ($185k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.29 | 1,301 | $47K | 25.5% |
| 2 | $37.23 | 3,699 | $138K | 74.5% |
| Total | $36.99 avg | 5,000 | $185K | 100% |
| Filing → |
| ENTA | SELL | 2023-12-06 | $23K | — | Filing → |
| ENTA | SELL | 2023-03-17 | $1.2M | — | Filing → |
| ENTA | SELL | 2019-03-04 | $2.1M | — | Filing → |